rethinkTHC Search
Menu
Study breakdown

Adolescent Dabbing Case Shows How High-Potency Cannabis May Speed Up Cannabinoid Hyperemesis Syndrome

Case ReportPreliminary evidence
The takeaway

A case of severe cannabinoid hyperemesis syndrome in an adolescent using high-potency cannabis products like dabs and THC edibles suggests that stronger products may cause this condition to develop faster and in younger users.

Read this if you or someone you know uses high-potency cannabis products and experiences episodes of unexplained nausea or vomiting.

High-potency products like dabs may speed up CHS onset in younger users

What the researchers found

An anxious, dehydrated teenager arrived at the emergency department with uncontrollable vomiting, weight loss, and abdominal pain. He reported that bathing and drinking large amounts of water were the only things that helped. He initially admitted only to social marijuana use.

Multiple medications failed to control his symptoms, including benzodiazepines, antipsychotics, and anti-nausea drugs. After extensive medical testing found no other cause, the patient was referred to psychiatric care. Only under more detailed questioning did the full picture emerge: prior chemical dependency treatment, drug-related legal charges, and heavy daily use including dabbing, THC candy, and smoking several grams per day.

The authors warn that with the rise of high-potency products like concentrates and edibles, cannabinoid hyperemesis syndrome is likely to appear more frequently, in younger patients, and with shorter use histories than historically expected.

Why it matters

This case illustrates two important trends: the diagnostic challenge cannabinoid hyperemesis syndrome poses (especially when patients underreport use), and the emerging concern that today's high-potency products may accelerate the condition's onset. Historically, CHS required over a year of heavy daily use. Products like dabs may compress that timeline.

The numbers in context

Patient used multiple high-potency products daily including dabs, THC candy, and several grams of smoked cannabis. Multiple medication classes (benzodiazepines, antipsychotics, antiemetics) failed to control symptoms. Historical CHS typically required over one year of heavy daily use.

How the study worked

Case report of a single adolescent patient presenting to an emergency department. Clinical course, diagnostic workup, and treatment attempts are described. The diagnosis of cannabinoid hyperemesis syndrome was made after extensive testing ruled out other causes.

What this study cannot tell us

Single case report with limited generalizability. The exact duration and quantity of the patient's cannabis use could not be precisely documented. The mechanisms by which high-potency products might accelerate CHS remain speculative.

How to read the evidence

Single case report providing clinical illustration but no statistical evidence. Useful for generating hypotheses about potency and CHS risk.

When this study was published

Published in 2016. Dabbing and high-potency concentrates have become significantly more common since.

The bigger picture

As cannabis products grow stronger and more varied, the clinical landscape is shifting. Emergency departments and primary care providers need to have high suspicion for CHS, especially in young patients with unexplained vomiting. The financial and medical cost of extensive diagnostic workups before reaching this diagnosis is significant.

Questions still open

  • Is there a THC dose threshold that triggers cannabinoid hyperemesis syndrome? Does the route of administration (dabbing vs. smoking vs. edibles) affect CHS risk independently of total THC consumed?

Common questions

What is cannabinoid hyperemesis syndrome?
CHS is a condition in heavy cannabis users characterized by severe cyclic vomiting, abdominal pain, and relief from hot bathing. It resolves when cannabis use stops.
Do dabs increase the risk of CHS?
This case and the authors' clinical experience suggest that high-potency products like dabs may cause CHS to develop faster and in younger users than traditional cannabis smoking.

Read the original research

Case Report of Intractable Vomiting and Abdominal Pain Related to Heavy Daily Cannabis Use.

South Dakota medicine : the journal of the South Dakota State Medical Association, No, 60-63

Citation

Gammeter, William Bryce; Duke, Kyle A; Soundy, Timothy J. (2016). Case Report of Intractable Vomiting and Abdominal Pain Related to Heavy Daily Cannabis Use.. South Dakota medicine : the journal of the South Dakota State Medical Association, No, 60-63.

Explore the wider topic